digital PCR
The Ultra-dPCR method purports to create approximately 30 million droplets using a low-cost consumable and standard lab instruments.
Qiagen Cites Competitive Advantages in Digital PCR, Sequencing Assays as Part of Core Growth Plan
Premium
On a call with investors to discuss third quarter results, the firm also offered updates on its syndromic testing and NeuMoDx businesses.
Bio-Rad Laboratories, NuProbe USA Ink Licensing and Development Agreement
NuProbe will exclusively license its allele enrichment technologies to Bio-Rad for the development of multiplexed digital PCR assays.
Naveris Nabs $33.4M Series A Round Expansion to Further Commercialize Virus-Related Cancer Tests
The new funding brings the total investment in the firm to $51 million, which Naveris will use for commercialization of its NavDx assay.
Company researchers recently demonstrated the attributes of the research-use-only system in a 43-target, two-tube multiplex dPCR test for EGFR mutations.